Clinical Trial NCT05389449
Trial
Alexion – ALXN2040-PNH-303
Clinical trial ID
NCT05389449
Drug name
ALXN2040, ACH- 0144471, Danicopan
Company:
Alexion
Drug trade name
Voydeya®
Phase of study
3
Current status
Active, not recruiting
Start
10/2022
Substance
Low molecular compound
Research question
LTE add on to C5i treatment in patients previously treatedwith danicopan
Delivery method of drug
Oral
Frequency
3 x daily
Clinical trial locations
UK USA Italy